Trends in death and life lost due to bladder cancer in Suzhou Cityfrom 2003 to 2022
WANG Yiqian1, WANG Linchi2, HUANG Chunyan2, CUI Junpeng2, LU Yan1,2
1. School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China; 2. Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu 215004, China
Abstract：Objective To analyze the trends in mortality and life lost due to bladder cancer in Suzhou City, Jiangsu Province from 2003 to 2022, so as to provide the reference for prevention and treatment strategy of bladder cancer. Methods The data of bladder cancer death in Suzhou City from 2003 to 2022 were collected through Suzhou Residents' Death Registration System, including age, gender, date of death and underlying cause of death. The crude mortality, standardized mortality, years of potential life lost (PYLL), standardized years of potential life lost (SPYLL), years of potential life lost rate (PYLLR), standardized years of potential life lost rate (SPYLLR) and average years of life lost (AYLL) were calculated. The average annual percent change (AAPC) was used to analyze the trends in bladder cancer death and life lost. Results Totally 2 978 deaths occurred due to bladder cancer in Suzhou City from 2003 to 2022. The crude mortality was 2.22/105, which appeared a tendency towards a rise (AAPC=4.271%, P<0.05). The standardized mortality was 0.91/105, which appeared no significant changing trend (P>0.05). The standardized mortality was 1.58/105 in males and 0.37/105 in females, which appeared no significant tendency in males (P>0.05) and appeared a tendency towards a decline in females (AAPC=-2.331%, P<0.05). The age-specific crude mortality was low among people who aged under 45 years, began to rise among people aged over 45 years and peaked among people aged 60 years and older. The crude mortality of bladder cancer in males aged 60 years and older showed an increasing trend (AAPC=2.864%, P<0.05), but there was no significant tendency in females aged 60 years and older (P>0.05). The PYLL, SPYLL, PYLLR, SPYLLR and AYLL of bladder cancer were 5 020.00 person-years, 2 945.14 person-years, 0.04‰, 0.03‰ and 9.07 years per person. SPYLL, SPYLLR and AYLL showed an decreasing trend (AAPC=-2.867%, -3.321%, -3.738%, P<0.05). Conclusions The mortality of bladder cancer in Suzhou City appeared a tendency towards a rise from 2003 to 2022. The PYLL appeared a downward trend. Males aged 60 years and older are the key groups for the prevention and control of bladder cancer.
汪怡倩, 王临池, 黄春妍, 崔俊鹏, 陆艳. 2003—2022年苏州市膀胱癌死亡趋势与减寿分析[J]. 预防医学, 2024, 36(1): 9-12.
WANG Yiqian, WANG Linchi, HUANG Chunyan, CUI Junpeng, LU Yan. Trends in death and life lost due to bladder cancer in Suzhou Cityfrom 2003 to 2022. Preventive Medicine, 2024, 36(1): 9-12.
[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249. [2] ZI H,HE S H,LENG X Y,et al.Global,regional,and national burden of kidney,bladder,and prostate cancers and their attributable risk factors,1990-2019[J]. Mil Med Res,2021,8(1):1-15. [3] VAN HOOGSTRATEN L M C,VRIELING A,VAN DER HEIJDEN A G,et al.Global trends in the epidemiology of bladder cancer:challenges for public health and clinical practice[J]. Nat Rev Clin Oncol,2023,20(5):287-304. [4] 陈勇,伟李,昊黄力,等.新辅助化疗联合经尿道膀胱肿瘤电切术对膀胱癌病人肿瘤直径、尿液膀胱肿瘤抗原水平及复发率的影响[J].临床外科杂志,2023,31(2):152-155. [5] 楚楚,徐红,武鸣. 1990—2019年江苏省膀胱癌疾病负担与吸烟归因疾病负担研究[J]. 中国慢性病预防与控制,2023,31(2):140-144. [6] 于雷,刘娟,马小桐,等.基于年龄-时期-队列模型的中国膀胱癌发病死亡趋势分析[J]. 现代预防医学,2022,49(23):4253-4258. [7] 鲁欣,蒋栋铭,周雄,等. 2004—2018年全国膀胱癌死亡率的流行特征及变化趋势[J]. 上海预防医学,2021,33(10):887-892. [8] 苏州市统计局.《苏州统计年鉴-2020》[EB/OL]. [2023-12-04]. http://tjj.suzhou.gov.cn/sztjj/tjnj/nav_list.shtml. [9] 金佩玉,孙天水,席淑华.影响膀胱癌发生的职业和环境危险因素研究进展[J]. 环境与职业医学,2017,34(9):840-846. [10] 朱婉红,柳丽珍,蔡仙国. 台州市膀胱癌危险因素的病例对照研究[J]. 预防医学,2019,31(3):246-250. [11] VISWAMBARAM P,HAYNE D.Gender discrepancies in bladder cancer:potential explanations[J]. Expert Rev Anticancer Ther,2020,20(10):841-849. [12] 张颖,胡碧波,苗超. 余姚市居民主要慢性病死因分析[J]. 预防医学,2017,29(1):66-69. [13] 钟浩,李博. 膀胱癌的性别差异及其主要危险因素分析[J]. 山东医药,2011,51(39):102-103. [14] 程志伟. 利用年龄-时期-队列模型探讨中国膀胱癌死亡率的影响因素[D].郑州:郑州大学,2018. [15] 韩苏军,张思维,陈万青,等. 中国膀胱癌死亡现状及流行趋势分析[J]. 现代泌尿外科杂志,2013,18(3):228-232. [16] 王军,陈永胜,丁璐璐,等.1972—2016年启东市膀胱癌死亡趋势分析[J]. 预防医学,2021,33(4):344-348. [17] 陈蓉,许辉,李辉章,等.2010—2014年浙江省肿瘤登记地区膀胱癌发病与死亡分析[J]. 中国肿瘤,2019,28(2):115-119. [18] LENIS A T,LEC P M,CHAMIE K,et al.Bladder cancer:a review[J]. JAMA,2020,324(19):1980-1991. [19] 李慧超,刘硕,杨雷,等.2003—2017年北京市户籍居民膀胱癌发病和死亡分析[J]. 中国肿瘤,2021,30(8):614-618. [20] 刘洋. 中国汉族人群中XPC基因多态性与前列腺癌、膀胱癌发病风险的关联研究[D].重庆:中国人民解放军陆军军医大学,2012. [21] 倪建晓,吴文秀,苏依所,等. 2013—2020年瓯海区居民恶性肿瘤死亡趋势及减寿分析[J]. 预防医学,2022,34(4):413-418.
